Arcus Biosciences (RCUS) Commences Underwritten Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/19/2026

1. SPY
2. CRWV
3. EYPT
4. NVDA
5. SLN
6. SLGN
7. TSLA
8. MANE
9. ABBV
10. AIBT

Go back to Arcus Biosciences (RCUS) Commences Underwritten Public Offering of Common Stock

Arcus Biosciences, Inc. Announces Commencement of Underwritten Public Offering of Common Stock

May 27, 2020 4:46 PM EDT

HAYWARD, Calif.--(BUSINESS WIRE)-- Arcus Biosciences, Inc. (NYSE: RCUS), a clinical-stage biopharmaceutical company focused on creating innovative cancer therapies, today announced that it has commenced an underwritten public offering of its common stock. The company intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. All of the shares in the offering will be sold by Arcus Biosciences. The offering is subject to market and other conditions, and there can be no assurances... More